Home / 2016 / December (page 4)

Monthly Archives: December 2016

GLP-1 Recommendations

How comfortable are you in recommending the combination of a GLP-1 receptor agonist along with glargine insulin? 1- Very comfortable 2- Slightly comfortable 3- Neutral 4- Slightly uncomfortable 5- Very uncomfortable at this time Follow the link to share your response and see what your colleagues think!

Read More »

Question #863

Test Your Knowledge

Please select the drug class that best fits the description. This injectable drug class leads to increased insulin secretion, decreased glucagon secretion and slowed gastric emptying. One of its advantages is that its use can lead to weight loss: 1. DPP-4 inhibitors 2. GLP-1 receptor agonists 3. Dopamine-2 Agonists 4. SGLT-2 Inhibitors Did you get it right? Follow the link to find out!

Read More »

Dec. 8, 2016

It has been 10 years since Sitagliptin was approved by the FDA. When it was first approved there was a lot of pushback from prescribers to trying a new class, as the last class, the TZDs, had suffered through the problems with Rezulin and the cardiovascular problems associated with Actos …

Read More »